Guangdong Petrochemical 20 million tons of oil refining + 1.2 million tons of ethylene project construction completed 84% of the total progress
Time of Update: 2022-09-18
Guangdong Petrochemical Project - Combined Atmospheric and Vacuum Distillation Unit Achieved Mechanical CompletionUp to now, the overall construction progress of PetroChina Guangdong Petrochemical Project has completed more than 84%, 26 main project units have been handed over, and the 220KV main substation and other public engineering units have entered the official operation stage, and are sprinting towards the goal of full completion and commissioning in 2022 .
In November 2019, China's plastic product output increased by 27.98% year-on-year
Time of Update: 2022-08-22
7% year-on-year According to the statistics of large-scale enterprises in November: From January to November, the cumulative output of plastic products of industrial enterprises above designated size in China was 71.
Lin Shuhai's research group co-published a research paper in the "Proceedings of the National Academy of Sciences" to identify metabolites that regulate the level of new crown antibodies
Time of Update: 2022-08-20
Since the outbreak of COVID-19, Lin Shuhai's research group has carried out a series of metabolism-related studies, and has cooperated to identify metabolic markers in different stages of COVID-19 (National Science Review 2020), as well as the abnormal analysis of milk proteins and metabolites in maternal patients with COVID-19.
Tens of billions of antithrombotic drugs have fallen into the "Altar"! TOP10 ranking changes
Time of Update: 2021-12-05
According to data from Meinenet, the market for terminal antithrombotic drugs in public medical institutions in China in 2021H1 increased by 13.
Ticagrelor tablets ranked sixth in the TOP10 terminal antithrombotic drug products of China's public medical institutions in 2020, and fell out of the top ten in 2021H1 .
The safety and effectiveness of young people's vaccination exceeds 90%, the results of Phase 3 of Moderna's new crown vaccine are published
Time of Update: 2021-08-28
This placebo-controlled trial covering more than 3700 people showed that the safety of two doses of mRNA-1273 vaccine for adolescents aged 12-17 years is acceptable, and the response after vaccination is similar to that of other age groups; the immune response is similar to that of young adults (18-25 years old) Similarly, high levels of neutralizing antibodies are produced, and two doses of mRNA-1273 vaccine can also effectively prevent the new coronavirus disease (COVID-19) in adolescents .
China's vaccine sales in the first half of the year are expected to hit the world's first
Time of Update: 2021-08-27
Looking back at the company's announcements in the past six months, it can be found that the main reason for the sharp increase in the profit of China Biopharmaceuticals is mainly from the revenue of Kexing Zhongwei vaccine .
New volume procurement: nearly half of the price limit is less than 1 yuan, and the minimum price is only 1 Mao. It is difficult to win the bid without reducing 50
Time of Update: 2019-12-30
Author: on the eve of new year's Day (December 29), a new round of belt purchasing document was issued, 33 varieties were officially selected, and January 17, 2020 (lunar month 23) was the bidding day